Joseph Doyle
Overview
Explore the profile of Joseph Doyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
710
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walker S, Rathnayake K, Dietze P, Higgs P, Ward B, Hellard M, et al.
Health Justice
. 2025 Jan;
13(1):6.
PMID: 39847147
Background: During the COVID-19 pandemic, governments worldwide introduced law enforcement measures to deter and punish breaches of emergency public health orders. For example, in Victoria, Australia, discretionary fines of A$1,652...
2.
Martinello M, Carson J, Post J, Finlayson R, Baker D, Read P, et al.
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae665.
PMID: 39691290
Background: Approximately 10% of people with HIV in Australia had active hepatitis C virus (HCV) infection prior to availability of government-subsidized direct-acting antiviral (DAA) therapy in 2016. This analysis evaluated...
3.
Ginnane J, Scott N, Radley A, Dillon J, Hellard M, Doyle J
J Viral Hepat
. 2024 Oct;
32(4):e14015.
PMID: 39440902
Meeting the World Health Organisation 2030 target of treating 80% of people with hepatitis C virus (HCV) in Australia requires accessible testing and treatment services for at-risk populations. Previous clinical...
4.
Lucocq J, Haugk B, Joseph N, Hawkyard J, White S, Mownah O, et al.
HPB (Oxford)
. 2024 Jul;
26(11):1421-1428.
PMID: 39084948
Background: Intraductal oncocytic papillary neoplasms (IOPNs) of the pancreas are now considered a separate entity to intraductal papillary mucinous neoplasms (IPMN). Invasive IOPNs are extremely rare, and their recurrence patterns,...
5.
Lucocq J, Haugk B, Parkinson D, Darne A, Joseph N, Hawkyard J, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):7023-7032.
PMID: 38961040
Background: The clinico-oncological outcomes of precursor epithelial subtypes of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN) are limited to small cohort studies. Differences in recurrence patterns and response to...
6.
Lucocq J, Joseph N, Hawkyard J, Haugk B, White S, Lye J, et al.
Surgery
. 2024 Jun;
176(3):890-898.
PMID: 38918108
Background: Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasms are unknown. This study determines predictors of long-term (>5 years) disease-free survival and recurrence in...
7.
Lucocq J, Hawkyard J, Haugk B, Mownah O, Menon K, Furukawa T, et al.
Br J Surg
. 2024 Apr;
111(4).
PMID: 38659247
Background: The clinical impact of adjuvant chemotherapy after resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia is unclear. The aim of this study was to identify factors related to...
8.
Lucocq J, Halle-Smith J, Haugk B, Joseph N, Hawkyard J, Lye J, et al.
Ann Surg
. 2024 Mar;
PMID: 38516777
Objective: The aim of the present study was to compare long-term post-resection oncological outcomes between A-IPMN and PDAC. Summary Background Data: Knowledge of long term oncological outcomes (e.g recurrence and...
9.
Yeung K, Doyle J, Kumar S, Aitken K, Tait D, Cunningham D, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38275893
Introduction: Neoadjuvant treatment (NAT) for borderline (BD) or locally advanced (LA) primary pancreatic cancer (PDAC) is now a widely adopted approach. We present a case series of patients who have...
10.
Doyle J, Alsan M, Skelley N, Lu Y, Cawley J
JAMA Intern Med
. 2023 Dec;
184(2):154-163.
PMID: 38147326
Importance: Food-as-medicine programs are becoming increasingly common, and rigorous evidence is needed regarding their effects on health. Objective: To test whether an intensive food-as-medicine program for patients with diabetes and...